Latest News and Press Releases

Independent DSMB reports zero device-related safety issuesSupports potential clinical benefitTrial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE)...

IJME publication of QUELIMMUNE therapy for pediatric AKI shows a potential for hospitals to incur no out-of-pocket costs for 6 days of treatment.

DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...

CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"

CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"

Chicago, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Continuous Renal Replacement Therapy market in terms of revenue was estimated to be worth $1.4 Billion in 2023 and is poised to reach $2.1 billion by 2028,...

Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Global Continuous Renal Replacement Therapy (CRRT) market size was valued at USD 1.01 billion in 2022 The market is anticipated to expand from USD 1.76...

Chicago, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the new market research report Published by MarketsandMarkets, "Continuous Renal Replacement Therapy Market by Product (Disposables...

– The SCD is currently being evaluated by the FDA for a Humanitarian Device Exemption (HDE) marketing approval for use in children (> 20 kgs) with AKI – The Company expects the FDA to complete...

EDEN PRAIRIE, Minn., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough...